Requirement for DCP-1 caspase during Drosophila oogenesis

Science

Volumn 279, Issue 5348, 1998, Pages 230-234

  McCall, Kimberly ^a   Steller, Hermann ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CYTOSKELETON; DROSOPHILA; ENZYME ACTIVITY; FEMALE STERILITY; NONHUMAN; OOCYTE DEVELOPMENT; PRIORITY JOURNAL;

ACTINS; ANIMALS; APOPTOSIS; CASPASES; CELL MEMBRANE; CYSTEINE ENDOPEPTIDASES; CYTOPLASM; CYTOSKELETON; DROSOPHILA; DROSOPHILA PROTEINS; FEMALE; LAMINS; MUTATION; NUCLEAR ENVELOPE; NUCLEAR PROTEINS; OOCYTES; OOGENESIS; OVARY; PHENOTYPE;

ANIMALIA;

EID: 0032498138     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.279.5348.230     Document Type: Article

References (56)

1. J. F. R. Kerr, A. H. Wyllie, A. R. Currie, Br. J. Cancer 26, 239 (1972).
2. J. W. Saunders Jr., Science 154, 604 (1966); M. C. Raff, Nature 356, 397 (1992); M. D. Jacobson, M. Weil, M. C. Raff, Cell 88, 347 (1997).
3. J. W. Saunders Jr., Science 154, 604 (1966); M. C. Raff, Nature 356, 397 (1992); M. D. Jacobson, M. Weil, M. C. Raff, Cell 88, 347 (1997).
4. J. W. Saunders Jr., Science 154, 604 (1966); M. C. Raff, Nature 356, 397 (1992); M. D. Jacobson, M. Weil, M. C. Raff, Cell 88, 347 (1997).
5. M. Adachi et al., Nature Genet. 11, 294 (1995); M. E. Grether, J. M. Abrams, J. Agapite, K. White, H. Steller, Genes Dev. 9, 1694 (1995); K. Kuida et al., Nature 384, 368 (1996).
6. M. Adachi et al., Nature Genet. 11, 294 (1995); M. E. Grether, J. M. Abrams, J. Agapite, K. White, H. Steller, Genes Dev. 9, 1694 (1995); K. Kuida et al., Nature 384, 368 (1996).
7. M. Adachi et al., Nature Genet. 11, 294 (1995); M. E. Grether, J. M. Abrams, J. Agapite, K. White, H. Steller, Genes Dev. 9, 1694 (1995); K. Kuida et al., Nature 384, 368 (1996).
8. F. Giorgi and P. Deri, J. Embryol. Exp. Morphol. 35, 521 (1976); M. O. Hengartner, in C. elegans II, D. L. Riddle, T. Blumenthal, B. J. Meyer, J. R. Priess, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1997), pp. 383-415; M. De Felici, Cell Death Differ. 4, 169 (1997).
9. F. Giorgi and P. Deri, J. Embryol. Exp. Morphol. 35, 521 (1976); M. O. Hengartner, in C. elegans II, D. L. Riddle, T. Blumenthal, B. J. Meyer, J. R. Priess, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1997), pp. 383-415; M. De Felici, Cell Death Differ. 4, 169 (1997).
10. F. Giorgi and P. Deri, J. Embryol. Exp. Morphol. 35, 521 (1976); M. O. Hengartner, in C. elegans II, D. L. Riddle, T. Blumenthal, B. J. Meyer, J. R. Priess, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1997), pp. 383-415; M. De Felici, Cell Death Differ. 4, 169 (1997).
11. R. C. King, Ovarian Development in Drosophila melanogaster (Academic Press, New York, 1970).
12. A. C. Spradling, in The Development of Drosophila melanogaster, M. Bate and A. Martinez Arias, Eds. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1993), vol. 1, pp. 1-70.
13. H. O. Gutzeit, J. Cell Sci. 80, 159 (1986); K. A. Edwards and D. P. Kiehart, Development 122, 1499 (1996); S. Wheatley, S. Kulkarni, R. Karess, ibid. 121, 1937 (1995).
14. H. O. Gutzeit, J. Cell Sci. 80, 159 (1986); K. A. Edwards and D. P. Kiehart, Development 122, 1499 (1996); S. Wheatley, S. Kulkarni, R. Karess, ibid. 121, 1937 (1995).
15. H. O. Gutzeit, J. Cell Sci. 80, 159 (1986); K. A. Edwards and D. P. Kiehart, Development 122, 1499 (1996); S. Wheatley, S. Kulkarni, R. Karess, ibid. 121, 1937 (1995).
16. L. Cooley, E. Verheyen, K. Ayers, Cell 69, 173 (1992).
17. L. Zamboni and B. Gondos, J. Cell Biol. 36, 276 (1968); J. R. Ruby, R. F. Dyer, R. G. Skalko, J. Morphol. 127, 307 (1969).
18. L. Zamboni and B. Gondos, J. Cell Biol. 36, 276 (1968); J. R. Ruby, R. F. Dyer, R. G. Skalko, J. Morphol. 127, 307 (1969).
19. E. S. Alnemri et al., Cell 87, 171 (1996); A. M. Chinnaiyan and V. M. Dixit, Curr. Biol. 6, 555 (1996); T. Patel, G. J. Gores, S. H. Kaufman, FASEB J. 10, 587 (1996); A. Takahashi and W. C. Earnshaw, Curr. Opin. Genet. Dev. 6, 50 (1996); A. G. Porter, P. Ng, R. U. Jänicke, Bioessays 19, 501 (1997).
20. E. S. Alnemri et al., Cell 87, 171 (1996); A. M. Chinnaiyan and V. M. Dixit, Curr. Biol. 6, 555 (1996); T. Patel, G. J. Gores, S. H. Kaufman, FASEB J. 10, 587 (1996); A. Takahashi and W. C. Earnshaw, Curr. Opin. Genet. Dev. 6, 50 (1996); A. G. Porter, P. Ng, R. U. Jänicke, Bioessays 19, 501 (1997).
21. E. S. Alnemri et al., Cell 87, 171 (1996); A. M. Chinnaiyan and V. M. Dixit, Curr. Biol. 6, 555 (1996); T. Patel, G. J. Gores, S. H. Kaufman, FASEB J. 10, 587 (1996); A. Takahashi and W. C. Earnshaw, Curr. Opin. Genet. Dev. 6, 50 (1996); A. G. Porter, P. Ng, R. U. Jänicke, Bioessays 19, 501 (1997).
22. E. S. Alnemri et al., Cell 87, 171 (1996); A. M. Chinnaiyan and V. M. Dixit, Curr. Biol. 6, 555 (1996); T. Patel, G. J. Gores, S. H. Kaufman, FASEB J. 10, 587 (1996); A. Takahashi and W. C. Earnshaw, Curr. Opin. Genet. Dev. 6, 50 (1996); A. G. Porter, P. Ng, R. U. Jänicke, Bioessays 19, 501 (1997).
23. E. S. Alnemri et al., Cell 87, 171 (1996); A. M. Chinnaiyan and V. M. Dixit, Curr. Biol. 6, 555 (1996); T. Patel, G. J. Gores, S. H. Kaufman, FASEB J. 10, 587 (1996); A. Takahashi and W. C. Earnshaw, Curr. Opin. Genet. Dev. 6, 50 (1996); A. G. Porter, P. Ng, R. U. Jänicke, Bioessays 19, 501 (1997).
24. T. Rudel and G. M. Bokoch, Science 276, 1571 (1997).
25. Z. Song, K. McCall, H. Steller, ibid. 275, 536 (1997).
26. A. Fraser and G. Evan, EMBO J. 16, 2805 (1997); Z. Song and H. Steller, in preparation.
27. A. Fraser and G. Evan, EMBO J. 16, 2805 (1997); Z. Song and H. Steller, in preparation.
28. 2R-G13 were carried through the same procedures.
29. K. Foley and L. Cooley, in preparation.
30. The TUNEL method [Y. Gavrieli, Y. Sherman, S. A. Ben-Sasson, J. Cell Biol. 119, 493 (1992)] detects fragmented DNA in apoptotic cells. We used a protocol modified from K. White, E. Tahaoglu, and H. Steller [Science 271, 805 (1996)]. Briefly, dissected ovarioles were fixed in 4% paraformaldehyde in phosphate buffered saline plus heptane for 30 min, washed several times in PBT (phosphate-buffered saline plus 0.1% Tween 20), treated with proteinase K (10 μg/ml) for 5 min, washed in PBT, and treated as described with reagents from the Apoptag Plus kit (Oncorr, Gaithersburg, MD). For detection, an alkaline phosphatase-conjugated antibody to digoxigenin and reagents from the Genius kit were used (both from Boehringer Mannheim). The AO method also detects apoptotic cells [J. M. Abrams, K. White, L. I. Fessler, H. Steller, Development 117, 29 (1993)]. We used a protocol from (15). The dumpless phenotype was variable: In one experiment, 35% of dcp-1 GLC stage 14 egg chambers had a severe dumpless phenotype, and 63% of these were TUNEL-positive (also see Table 1). With either TUNEL or AO, a delay in apoptosis was observed in the dcp-1 GLCs. This delay, however, may not be directly due to loss of dcp-1 function because a delay in apoptosis is observed in other dumpless mutants (75). These authors have suggested that an inhibitor of apoptosis may be present in the nurse cells and that removal of the inhibitor by dumping is required for the completion of apoptosis.
31. The TUNEL method [Y. Gavrieli, Y. Sherman, S. A. Ben-Sasson, J. Cell Biol. 119, 493 (1992)] detects fragmented DNA in apoptotic cells. We used a protocol modified from K. White, E. Tahaoglu, and H. Steller [Science 271, 805 (1996)]. Briefly, dissected ovarioles were fixed in 4% paraformaldehyde in phosphate buffered saline plus heptane for 30 min, washed several times in PBT (phosphate-buffered saline plus 0.1% Tween 20), treated with proteinase K (10 μg/ml) for 5 min, washed in PBT, and treated as described with reagents from the Apoptag Plus kit (Oncorr, Gaithersburg, MD). For detection, an alkaline phosphatase-conjugated antibody to digoxigenin and reagents from the Genius kit were used (both from Boehringer Mannheim). The AO method also detects apoptotic cells [J. M. Abrams, K. White, L. I. Fessler, H. Steller, Development 117, 29 (1993)]. We used a protocol from (15). The dumpless phenotype was variable: In one experiment, 35% of dcp-1 GLC stage 14 egg chambers had a severe dumpless phenotype, and 63% of these were TUNEL-positive (also see Table 1). With either TUNEL or AO, a delay in apoptosis was observed in the dcp-1 GLCs. This delay, however, may not be directly due to loss of dcp-1 function because a delay in apoptosis is observed in other dumpless mutants (75). These authors have suggested that an inhibitor of apoptosis may be present in the nurse cells and that removal of the inhibitor by dumping is required for the completion of apoptosis.
32. The TUNEL method [Y. Gavrieli, Y. Sherman, S. A. Ben-Sasson, J. Cell Biol. 119, 493 (1992)] detects fragmented DNA in apoptotic cells. We used a protocol modified from K. White, E. Tahaoglu, and H. Steller [Science 271, 805 (1996)]. Briefly, dissected ovarioles were fixed in 4% paraformaldehyde in phosphate buffered saline plus heptane for 30 min, washed several times in PBT (phosphate-buffered saline plus 0.1% Tween 20), treated with proteinase K (10 μg/ml) for 5 min, washed in PBT, and treated as described with reagents from the Apoptag Plus kit (Oncorr, Gaithersburg, MD). For detection, an alkaline phosphatase-conjugated antibody to digoxigenin and reagents from the Genius kit were used (both from Boehringer Mannheim). The AO method also detects apoptotic cells [J. M. Abrams, K. White, L. I. Fessler, H. Steller, Development 117, 29 (1993)]. We used a protocol from (15). The dumpless phenotype was variable: In one experiment, 35% of dcp-1 GLC stage 14 egg chambers had a severe dumpless phenotype, and 63% of these were TUNEL-positive (also see Table 1). With either TUNEL or AO, a delay in apoptosis was observed in the dcp-1 GLCs. This delay, however, may not be directly due to loss of dcp-1 function because a delay in apoptosis is observed in other dumpless mutants (75). These authors have suggested that an inhibitor of apoptosis may be present in the nurse cells and that removal of the inhibitor by dumping is required for the completion of apoptosis.
33. Ultrastructural analysis has revealed large (0.5 μm) gaps in the nuclear envelope of nurse cells before the stage of nurse cell dumping [E. Okada and C. H. Waddington, J. Embryol. Exp. Morphol. 7, 583 (1959); A. P. Mahowald and M. P. Kambysellis, in The Genetics and Biology of Drosophila, M. Ashburner and T. R. F. Wright, Eds. (Academic Press, New York, 1980), vol. 2d, pp. 141-224]. With a nuclear β-Gal marker, wild-type nurse cell nuclei become permeable during stage 10B, with β-Gal leakage into the cytoplasm (8). Both dcp-1 alleles are caused by insertion of P elements that carry a nuclear β-Gal marker (12). We examined either heterozygous dcp-1/CyO or dcp-7 GLC ovaries for β-Gal activity using X-gal as a substrate. We followed the protocol in (31), except that ovaries were fixed in 1% glutaraldehyde [in 0.1 M phosphate buffer (pH 6.9)] for 7 min.
34. Ultrastructural analysis has revealed large (0.5 μm) gaps in the nuclear envelope of nurse cells before the stage of nurse cell dumping [E. Okada and C. H. Waddington, J. Embryol. Exp. Morphol. 7, 583 (1959); A. P. Mahowald and M. P. Kambysellis, in The Genetics and Biology of Drosophila, M. Ashburner and T. R. F. Wright, Eds. (Academic Press, New York, 1980), vol. 2d, pp. 141-224]. With a nuclear β-Gal marker, wild-type nurse cell nuclei become permeable during stage 10B, with β-Gal leakage into the cytoplasm (8). Both dcp-1 alleles are caused by insertion of P elements that carry a nuclear β-Gal marker (12). We examined either heterozygous dcp-1/CyO or dcp-7 GLC ovaries for β-Gal activity using X-gal as a substrate. We followed the protocol in (31), except that ovaries were fixed in 1% glutaraldehyde [in 0.1 M phosphate buffer (pH 6.9)] for 7 min.
35. F. A. Oberhammer, K. Hochegger, G. Fröschl, R. Tiefenbacher, M. Pavelka, J. Cell Biol. 126, 827 (1994); N. Neamati, A. Fernandez, S. Wright, J. Kiefer, D. J. McConkey, J. Immunol. 154, 3788 (1995); Y. Lazebnik et al., Proc. Natl. Acad. Sci. U.S.A. 92, 9042 (1995); K. Orth, A. M. Chinnaiyan, M. Garg, C. J. Froelich, V. M. Dixit, J. Biol. Chem. 271, 16443 (1996).
36. F. A. Oberhammer, K. Hochegger, G. Fröschl, R. Tiefenbacher, M. Pavelka, J. Cell Biol. 126, 827 (1994); N. Neamati, A. Fernandez, S. Wright, J. Kiefer, D. J. McConkey, J. Immunol. 154, 3788 (1995); Y. Lazebnik et al., Proc. Natl. Acad. Sci. U.S.A. 92, 9042 (1995); K. Orth, A. M. Chinnaiyan, M. Garg, C. J. Froelich, V. M. Dixit, J. Biol. Chem. 271, 16443 (1996).
37. F. A. Oberhammer, K. Hochegger, G. Fröschl, R. Tiefenbacher, M. Pavelka, J. Cell Biol. 126, 827 (1994); N. Neamati, A. Fernandez, S. Wright, J. Kiefer, D. J. McConkey, J. Immunol. 154, 3788 (1995); Y. Lazebnik et al., Proc. Natl. Acad. Sci. U.S.A. 92, 9042 (1995); K. Orth, A. M. Chinnaiyan, M. Garg, C. J. Froelich, V. M. Dixit, J. Biol. Chem. 271, 16443 (1996).
38. F. A. Oberhammer, K. Hochegger, G. Fröschl, R. Tiefenbacher, M. Pavelka, J. Cell Biol. 126, 827 (1994); N. Neamati, A. Fernandez, S. Wright, J. Kiefer, D. J. McConkey, J. Immunol. 154, 3788 (1995); Y. Lazebnik et al., Proc. Natl. Acad. Sci. U.S.A. 92, 9042 (1995); K. Orth, A. M. Chinnaiyan, M. Garg, C. J. Froelich, V. M. Dixit, J. Biol. Chem. 271, 16443 (1996).
39. L. Rao, D. Perez, E. White, J. Cell Biol. 135, 1441 (1996).
40. R. D. Moir, T. P. Spann, R. D. Goldman, Int. Rev. Cytol. 162B, 141 (1995).
41. 0 [D. E. Smith and P. A. Fisher, J. Cell Biol. 108, 255 (1989)].
42. 0 [D. E. Smith and P. A. Fisher, J. Cell Biol. 108, 255 (1989)].
43. 0 [D. E. Smith and P. A. Fisher, J. Cell Biol. 108, 255 (1989)].
44. Z. Song and H. Steller, in preparation.
45. L. Cooley and W. E. Theurkauf, Science 266, 590 (1994); B. A. Knowles and L. Cooley, Trends Genet. 10, 235 (1994).
46. L. Cooley and W. E. Theurkauf, Science 266, 590 (1994); B. A. Knowles and L. Cooley, Trends Genet. 10, 235 (1994).
47. Rhodamine-phalloidin (Molecular Probes) staining was performed essentially as in (31). Images were visualized on a Bio-Rad confocal microscope. Because of variability in the phenotype, cytoplasmic actin bundles were found in some dcp-7 GLC egg chambers (Table 3). However, only 7% of the late-stage severely dumpless egg chambers showed actin bundles.
48. K. Cant, B. A. Knowles, M. S. Mooseker, L. Cooley, J. Cell Biol. 125, 369 (1994).
49. S. A. Jewell, G. Bellomo, H. Thor, S. Orrenius, M. T. Smith, Science 217, 1257 (1982).
50. T. G. Cotter, S. V. Lennon, J. M. Glynn, D. R. Green, Cancer Res. 52, 997 (1992).
51. C. Brancolini, M. Benedetti, C. Schneider, EMBO J. 14, 5179 (1995); S. J. Martin et al., J. Biol. Chem. 270, 6425 (1995).
52. C. Brancolini, M. Benedetti, C. Schneider, EMBO J. 14, 5179 (1995); S. J. Martin et al., J. Biol. Chem. 270, 6425 (1995).
53. G. Kroemer, Cell Death Differ. 4, 443 (1997).
54. S. Tourmente, P. Lecher, F. Degroote, M. Renaud, Biol. Cell 66, 119 (1990).
55. E. Verheyen and L. Cooley, Methods Cell Biol. 44, 545 (1994).
56. 0 antibodies; and S. Chattarji for advice on the confocal microscope. Supported by the American Cancer Society (K.M.) H.S. is an investigator of the Howard Hughes Medical Institute.